Longeveron (LGVN) Depreciation and Depletion (2023 - 2024)
Longeveron's (LGVN) quarterly Depreciation and Depletion came in at $200000.0 in Q3 2024, little changed year-on-year from $200000.0 in Q4 2023, and little changed quarter-over-quarter from $200000.0 in Q3 2023.
Longeveron (LGVN) Depreciation and Depletion (2023 - 2024) Analysis & Trends
Longeveron's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $200000.0 for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | Longeveron | 15.36 Bn | 15.34 Bn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |